SourceBio International PLC Investor presentation
13 January 2021 - 6:00PM
RNS Non-Regulatory
TIDMSBI
SourceBio International PLC
13 January 2021
SourceBio International plc
("SourceBio", the "Company" or the "Group")
Investor presentation
SourceBio International plc (AIM: SBI), an international
provider of integrated state-of-the-art laboratory services and
products, announces it will present at the Shares Investor Evening
Webinar, providing an overview of the business and progress being
made by the Company .
Jay LeCoque, Executive Chairman, will present online at the
Shares Spotlight webinar on Wednesday 20 January 2021. The event
starts at 18.00 and Jay will start presenting promptly at
approximately 19.20. The event attracts investors to companies
across various sectors and welcomes existing investors along with
those looking for new investment opportunities. Investors can
register to attend here: https://bit.ly/3sjqqiI
No new material information will be disclosed at the event and
the presentation will be made available on the Company website
shortly after the events here:
https://sourcebiointernational.com/corporate-presentation-confirmation/
Contacts:
SourceBio International plc www.sourcebiointernational.com
Jay LeCoque, Executive Chairman Via Walbrook PR
Tony Ratcliffe, Chief Financial Officer
Walbrook PR Limited Tel: 020 7933 8780 or sourcebio@walbrookpr.com
Paul McManus / Sam Allen Mob: 07980 541 893 / 07748
651 727
About SourceBio International plc
www.sourcebiointernational.com
SourceBio is a leading international provider of integrated
state-of-the-art laboratory services and products clients in the
healthcare, clinical, life science research and biopharma
industries, with a focus on improving patient diagnosis, management
and care. Group revenues are derived from four core businesses
areas:
-- Healthcare Diagnostics - histopathology and clinical
diagnostic services for the NHS and private healthcare across the
UK and Ireland.
-- Genomics - DNA sequencing services for pharmaceutical and
biotechnology companies, academia, contract research organisations
(CROs) and other research groups in the UK, Europe and North
America.
-- Stability Storage - shelf-life testing services and equipment
for pharmaceutical and biotechnology companies, contract
manufacturers and analytical testing companies from around the
world but primarily in the UK, Ireland and the USA; and
-- Infectious Disease Testing - since May 2020, the Group has
provided COVID-19 Antigen RT-PCR testing services. These services
passed all of the auditing requirements of the NHS and the
Department of Health and Social Care (DHSC) in April 2020. It is
intended that this offering will potentially provide a broad range
of infectious disease testing across the NHS, private healthcare
and commercial sectors in the future.
More details on Group operations can be found here:
www.sourcebioscience.com
SourceBio International plc (SBI.L) is listed on the AIM market
of the London Stock Exchange.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRABTMPTMTMBBRB
(END) Dow Jones Newswires
January 13, 2021 02:00 ET (07:00 GMT)
Sourcebio (LSE:SBI)
Historical Stock Chart
From Nov 2024 to Dec 2024
Sourcebio (LSE:SBI)
Historical Stock Chart
From Dec 2023 to Dec 2024
